Prudential Financial Inc Cara Therapeutics, Inc. Transaction History

Prudential Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$4.89 - $12.27 $9,706 - $24,355	-1,985 Reduced 4.34%	43,747 $214,000
Q3 2022 Nov 04, 2022	BUY	$8.24 - $12.56 $17,015 - $25,936	2,065 Added 4.73%	45,732 $428,000
Q2 2022 Aug 15, 2022	SELL	$7.45 - $13.84 $2,719 - $5,051	-365 Reduced 0.83%	43,667 $399,000
Q1 2022 May 13, 2022	SELL	$9.94 - $12.65 $5,964 - $7,590	-600 Reduced 1.34%	44,032 $535,000
Q4 2021 Feb 14, 2022	BUY	$11.99 - $18.14 $4,436 - $6,711	370 Added 0.84%	44,632 $544,000

Q3 2021 Nov 15, 2021	SELL	$11.55 - $16.06 $27,581 - $38,351	-2,388 Reduced 5.12%	44,262 $684,000
Q2 2021 Aug 16, 2021	BUY	$12.38 - $29.19 $577,527 - $1.36 Million	46,650 New	46,650 $666,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.